Form D · Other Health Care
Kairo Health Labs, Inc.
San Carlos, CA · CIK 0002147630
Offering snapshot reported Aug 10, 2026 · SEC filing
- Reported sold
- $200K Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 3, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2026 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-593660
Source: Form D, filed Aug 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| S Indhu Kiranmai Ernala | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2017 Brittan Avenue
San Carlos, CA, 94070
San Carlos, CA, 94070